Quantitative synthetic MRI for predicting locally advanced rectal cancer response to neoadjuvant chemoradiotherapy.

Eur Radiol

Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China.

Published: March 2023

AI Article Synopsis

  • The study aimed to evaluate synthetic MRI as a tool for predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer.
  • Among 63 patients studied, significant differences were found in T1 and T2 relaxation times, which were lower in those who achieved pathologic complete response (pCR) and T-downstaging.
  • Despite promising findings, there were no significant differences in proton density or apparent diffusion coefficient values in predicting treatment outcomes.

Article Abstract

Objectives: To investigate the value of pre-treatment quantitative synthetic MRI (SyMRI) for predicting a good response to neoadjuvant chemoradiotherapy (nCRT) in patients with locally advanced rectal cancer.

Methods: This prospective study enrolled 63 patients with locally advanced rectal cancer scheduled to undergo preoperative chemoradiotherapy from January 2019 to June 2021. T1 relaxation time (T1), T2 relaxation time (T2), proton density (PD) from synthetic MRI, and apparent diffusion coefficient (ADC) from diffusion-weighted imaging (DWI) were measured. Independent-sample t-test, the Mann-Whitney U test, the Delong test, and receiver operating characteristic curve (ROC) analyses were used to predict the pathologic complete response (pCR) and T-downstaging.

Results: Among the 63 patients, 19 (30%) achieved pCR and 44 (70%) did not, and 24 (38%) achieved T-downstaging, while 44 (62%) did not. The mean T1 and T2 values were significantly lower in the pCR group compared with those in the non-pCR group and in the T-downstage group compared with those in the non-T-downstage group (all p < 0.05). There were no significant differences in the PD and ADC values between the two groups. There were no significant differences between the mean values of T1 and T2 for predicting pCR after CRT (AUC, 0.767 vs. 0.831, p = 0.37). There were no significant differences between the AUC values of T1 and T2 values for the assessment of post-CRT T-downstaging (AUC, 0.746 vs. 0.820, p = 0.506).

Conclusions: In patients with locally advanced rectal cancer, the synthetic MRI-derived T1 relaxation time and T2 relaxation time values are promising imaging markers for predicting a good response to neoadjuvant chemoradiotherapy.

Key Points: • Mean T1 and T2 values were significantly lower in the pathologic complete response group and the T-downstage group. • There were no significant differences in the proton density and apparent diffusion coefficient values between the two groups.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-022-09191-7DOI Listing

Publication Analysis

Top Keywords

locally advanced
16
advanced rectal
16
relaxation time
16
synthetic mri
12
rectal cancer
12
response neoadjuvant
12
patients locally
12
quantitative synthetic
8
neoadjuvant chemoradiotherapy
8
predicting good
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!